The latest price target for Morgan Stanley (NYSE:MS) was reported by Keefe, Bruyette & Woods on January 16, 2026. The analyst firm set a price target for $210.00 expecting MS to rise to within 12 months (a possible 14.75% upside). 33 analyst firms have reported ratings in the last year.

The latest analyst rating for Morgan Stanley (NYSE:MS) was provided by Keefe, Bruyette & Woods, and Morgan Stanley maintained their outperform rating.

The last upgrade for Morgan Stanley happened on November 24, 2025 when Wolfe Research raised their price target to N/A. Wolfe Research previously had a peer perform for Morgan Stanley.

The last downgrade for Morgan Stanley happened on November 26, 2024 when HSBC changed their price target from $128 to $131 for Morgan Stanley.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Morgan Stanley, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Morgan Stanley was filed on January 16, 2026 so you should expect the next rating to be made available sometime around January 16, 2027.

While ratings are subjective and will change, the latest Morgan Stanley (MS) rating was a maintained with a price target of $202.00 to $210.00. The current price Morgan Stanley (MS) is trading at is $183.00, which is out of the analyst’s predicted range.